Vecuronium Bromide
Product Images NDC 51662-1475
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 51662-1475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Dosage 1 (Dosage 1)
Dosage 2 (Dosage 2)
This is a drug infusion rate chart showing the recommended amount of vecuronium bromide (given in milliliters per minute) based on the patient's weight in kilograms. The chart is divided into weight categories ranging from 40 to 100 kg. The values listed under each weight category correspond to the amount of the drug that should be administered per minute.*
Hs Logo (How Supplied Logo)
How Supplied (How Supplied)
This is a list of two pharmaceutical products containing Vecuronium bromide in different quantities and packaging. The first product has 10 mg Vecuronium bromide in a 10 mL vial with a flip-top lid, while the second one has 20 mg Vecuronium bromide in a 25 mL vial with a flip-top lid. However, both products do not come with a diluent.*
Logo (Logo)
Serialized Vial Labeling (Serialized Vial)
VECURONIUM W is a medication intended for injection intravenously as a paralyzing agent. The product should be reconstituted with 10mL and has a concentration of 1mg/mL. The medication is distributed by HF Acquisition Co., LLC, and Hospira, Inc. The manufacturer's package insert should be consulted for further information.*
Structure (Structure)
Vial Label Opt. 1 (Vial Label Opt 1)
This text appears to be a warning label for a medication called VECURONIUM. It states that the medication is a paralyzing agent that can cause respiratory arrest and that facilities with artificial respiration capabilities should be readily available. Dosage information and storage instructions can be found in the package insert. The medication is given via injection and appropriate precautions should be taken. The medication is distributed by Hospira, Inc. However, the text is not complete and contains some errors, making it difficult to fully understand.*
Vial Label Opt. 2 (Vial Label Opt 2)
This appears to be a label for the medication VECURONIUM. It is a bromide injection used for medical purposes and the appropriate dosage details can be found on the package insert. The label shows that the vial contains 10mg. The rest of the text is either not readable or appears to be administrative data such as lot/exp numbers and check boxes.*
Vial Label Opt. 3 (Vial Label Opt 3)
This is medication with the NDC code of 0409-1632-01. The medication is Vecuronium and there is a warning to have artificial respiration immediately available. The package insert should be checked for more information. The medication is for IV use only and contains benzyl alcohol, therefore, it is not suitable for newborns. The medication must be used within 24 hours of reconstitution with supplied bacteriostatic water for injection. There is a dosage of 10 mg per vial when reconstituted to 10 mL. The package insert recommended reconstitution with sterile water for injection or compatible V. This medication is manufactured by Hospira, Inc. located in Lake Forest, IL 60045 USA with a preparation date of RL-2258 (8/07).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.